Literature DB >> 22653247

Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part II: potentially malignant and benign ventricular arrhythmias.

Konstantinos A Gatzoulis1, Stefanos Archontakis, Polychronis Dilaveris, Dimitrios Tsiachris, Petros Arsenos, Skevos Sideris, Christodoulos Stefanadis.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22653247

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN： 1109-9666


× No keyword cloud information.
  3 in total

1.  Deceleration Capacity of Heart Rate Predicts Arrhythmic and Total Mortality in Heart Failure Patients.

Authors:  Petros Arsenos; George Manis; Konstantinos A Gatzoulis; Polychronis Dilaveris; Theodoros Gialernios; Athanasios Angelis; Achileas Papadopoulos; Erifili Venieri; Athanasios Trikas; Dimitris Tousoulis
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-04-01       Impact factor: 1.468

2.  MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression.

Authors:  Xuefeng Cao; Zheng Zhang; Yu Wang; Weichao Shan; Ruiting Wang; Shufang Mao; Shi Ding; Chong Pang; Baoqun Li; Jian Zhou; Xiaoyan Guo; Na Guo; Cui Li; Jing Liang; Wenya Ma; Yu Liu; Liang Zhao
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

3.  Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE-EF study.

Authors:  Konstantinos Trachanas; Skevos Sideris; Petros Arsenos; Dimitrios Tsiachris; Christos-Konstantinos Antoniou; Polychronis Dilaveris; Konstantinos Triantafyllou; Iosif Xenogiannis; Konstantinos Tsimos; Michalis Efremidis; Emmanuel Kanoupakis; Panagiota Flevari; Vassilios Vassilikos; Antonios Sideris; Panagiotis Korantzopoulos; Dimitrios Tousoulis; Konstantinos Tsioufis; Konstantinos Gatzoulis
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-12-06       Impact factor: 1.468
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.